FTC Requests Public Comment on Otto Bock HealthCare North America, Inc.’s Application to Approve Divestiture of Assets It Gained through Acquisition of FIH Group Holdings, LLC
In November 2019, upholding an administrative law judges decision, the Commission unanimously found that the merger was anticompetitive, and it ordered the assets unwound.
- In November 2019, upholding an administrative law judges decision, the Commission unanimously found that the merger was anticompetitive, and it ordered the assets unwound.
- According to the divestiture application, Proteor, a French company with U.S. headquarters in Tempe, Arizona, is a well-established and reputable, worldwide manufacturer and supplier of lower-limb prosthetic devices.
- The divestiture application, along with instructions for filing comments, is available in the Federal Register.
- After a 30-day public comment period, the Commission will vote on whether to approve the application.